|
UBE2Z expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.203930E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.277510E-02 |
| Normal-vs-Stage2 |
8.446800E-01 |
| Normal-vs-Stage3 |
1.452950E-01 |
| Normal-vs-Stage4 |
3.384100E-03 |
| Stage1-vs-Stage2 |
8.309800E-02 |
| Stage1-vs-Stage3 |
4.872600E-01 |
| Stage1-vs-Stage4 |
1.532360E-01 |
| Stage2-vs-Stage3 |
3.150400E-01 |
| Stage2-vs-Stage4 |
1.804250E-02 |
| Stage3-vs-Stage4 |
1.008550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.010030E-02 |
| Normal-vs-AfricanAmerican |
8.534600E-01 |
| Normal-vs-Asian |
9.798000E-02 |
| Caucasian-vs-AfricanAmerican |
1.025170E-01 |
| Caucasian-vs-Asian |
1.876000E-01 |
| AfricanAmerican-vs-Asian |
1.668400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.362200E-02 |
| Normal-vs-Female |
1.740230E-03 |
| Male-vs-Female |
3.842300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.989400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.580000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.299100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.649600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.920960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.619400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.657000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.017800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.147800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.482200E-02 |
| Normal-vs-Grade 2 |
2.299900E-02 |
| Normal-vs-Grade 3 |
9.142300E-02 |
| Normal-vs-Grade 4 |
5.744000E-03 |
| Grade 1-vs-Grade 2 |
3.256600E-01 |
| Grade 1-vs-Grade 3 |
2.822200E-01 |
| Grade 1-vs-Grade 4 |
8.451600E-01 |
| Grade 2-vs-Grade 3 |
5.647200E-01 |
| Grade 2-vs-Grade 4 |
1.705770E-01 |
| Grade 3-vs-Grade 4 |
7.446000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.975500E-03 |
| Normal-vs-ccB subtype |
2.838500E-02 |
| ccA subtype-vs-ccB subtype |
9.812600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.921300E-03 |
| Normal-vs-N1 |
1.168470E-02 |
| N0-vs-N1 |
1.137800E-02 |
|
|
